Navigation Links
Prime Therapeutics named exclusive pharmacy benefit manager for HR Policy Association
Date:8/21/2012

ST. PAUL, Minn., Aug. 21, 2012 /PRNewswire/ -- Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM), has been selected as the exclusive PBM and third party administrator for the HR Policy Association's Pharmaceutical Coalition, the lead organization representing chief human resource officers of more than 330 of the largest corporations in the United States and globally. Through the new program, members of the coalition will have a fully transparent contractual agreement.

The new program passes on the cost of drugs and all financial benefits accrued directly to the employer, and costs will be fully transparent. This is unlike most traditional PBM relationships, due to misaligned contractual elements the employer doesn't know the actual costs of the drug paid by the PBM or the mark-ups added to that cost. The program will be available to coalition employers beginning January 1, 2013.

"Our new agreement with HR Policy Association's Pharmaceutical Coalition not only serves as a strong reinforcement of our continued commitment to transparency for all of our clients, it also confirms that we are a highly competitive player in the large employer market," said Eric Elliott, Prime president and CEO. "While we continue to be committed to an integrated medical and pharmacy model, we welcome the opportunity to expand access to Prime's high-quality, affordable pharmacy management to current and future HR Policy members. We believe this agreement will only strengthen our impact in this market as more and more customers realize the importance of Prime's unique value proposition."

Since 2006, the Coalition has been actively involved in increasing transparency in the PBM industry, through its Transparency in Pharmaceutical Purchasing Solutions (TIPPS) certification program. PBMs willing to meet high standards of transparency can receive annual certification. Prime was among the first PBMs to participate in the TIPPS initiative. It has received certification each year, including the highest level of certification last year.

"The HR Policy Association's Pharmaceutical Coalition program will now make it easier than ever for employers to provide affordable, quality prescription drug benefits to employees, retirees and their dependents." said Jeffrey C. McGuiness, Chief Executive Officer of the Association. "The Coalition is looking forward to working with Prime Therapeutics to advance the HR Policy Association's long-term goal of promoting transparency in pharmacy benefits."

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and customers. Providing pharmacy benefit services nationwide to nearly 20 million lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minn., Prime Therapeutics is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group
2. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
3. Lonza and BioWa Sign License Agreements with FivePrime Therapeutics for Use of Their POTELLIGENT® CHOK1SV Cell Line for Therapeutic Antibody Development
4. Vocollect Healthcare Systems And Prime Care Technologies Bring AccuNurse Key Performance Metrics To Long-Term Care Providers Via primeVIEW Digital Dashboard
5. Prime Therapeutics Named a Top Workplace by the Minneapolis Star Tribune
6. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
7. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
8. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... , July 11, 2017  The global market for ... of approximately $394.1 million in 2016.  Although in early ... solid growth, in particular as a result of the ... and the recent introduction of a significant number of ... less-invasive testing of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing a ... who suffer from painful intercourse and other painful pelvic pain conditions such ... to menopause. ... LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a void ...
(Date:7/10/2017)... , July 10, 2017  US medical equipment and ... 2021, according to Medical Equipment & Supplies: ... Freedonia Focus Reports. Continued increases in demand for medical ... of the population and supported by gains in disposable ... and supplies. New product introductions will also drive sales ...
Breaking Medicine Technology:
(Date:7/23/2017)... Opelousas, LA (PRWEB) , ... July 23, 2017 ... ... providers to interact, thus improving communication, safety and patient-provider relationships. New tools are ... according to results of the 19th Annual Health Care’s Most Wired® survey, released ...
(Date:7/23/2017)... ... July 23, 2017 , ... ... Florida Pain Relief Group – Melbourne, a practice owned by Physician Partners of ... interventional pain management, Dr. Stern also is certified in pediatrics, emergency medicine and ...
(Date:7/23/2017)... ... ... Viora Ltd., a leading medical aesthetics solutions manufacturer, is ... United States Patent and Trademark Office. The patent applies to treatments with Viora’s ... mechanisms to further increase the efficacy and safety of final treatment results for ...
(Date:7/22/2017)... , ... July 22, 2017 , ... ... year with the majority of patients not requiring pain medication after three months ... Sports Medicine’s Annual Meeting today in Toronto, Ontario, Canada found that those ...
(Date:7/21/2017)... PITTSBURGH, PA (PRWEB) , ... July 21, 2017 , ... ... I use a lot of pleural catheters available on the market," said an inventor ... level of comfort and safety for the patient." , He developed the patent-pending PLEURAL ...
Breaking Medicine News(10 mins):